NCT05993572 (HEAT-YASAM) is a clinical trial of Comprehensive Geriatric Assessment in Frailty, sponsored by Gulhane Training and Research Hospital.

Who is sponsoring NCT05993572?

NCT05993572 is sponsored by Gulhane Training and Research Hospital.

What drugs are being tested in NCT05993572?

Interventions in NCT05993572: Comprehensive Geriatric Assessment.

What condition does NCT05993572 study?

NCT05993572 studies Frailty, Dementia, Depression, Malnutrition, Old Age; Debility, Drug Use.

Is NCT05993572 still recruiting?

NCT05993572 is currently status unknown. Last updated 6 December 2023.

Last reviewed 2023-12-06 · How we verify

NCT05993572: HEAT-YASAM

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

HEalthy Aging Team Supported Home-care Services (HEAT-YASAM)

Status unknown Last updated 6 December 2023

What this trial tests

trial testing Comprehensive Geriatric Assessment in Frailty in 2,000 participants. Status unknown.

Timeline

15 June 2023

Primary endpoint
1 December 2024

1 December 2025

Quick facts

Lead sponsor	Gulhane Training and Research Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	2,000
Start date	15 June 2023
Primary completion	1 December 2024
Estimated completion	1 December 2025
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Comprehensive Geriatric Assessment

Conditions studied

Frailty — all drugs for Frailty →
Dementia — all drugs for Dementia →
Depression — all drugs for Depression →
Malnutrition — all drugs for Malnutrition →

Sponsor

Gulhane Training and Research Hospital

Who can join

80 and older, any sex, with Frailty or Dementia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Depending on the YASAM project which was established to home-visit evaluate community-dwelling older adults (80 years of age and over), we aimed to determine the prevalence (prevalence) of geriatric syndromes (dependence, frailty, malnutrition, depression, dementia, comorbidity burden, polypharmacy) in these individuals and to determine possible changes in the follow-up of the patients during the 2-year follow-up period. (HEAVEN trial)

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

A Community-Based Integrated Healthy Aging Program at a Tertiary Hospital (YASAM) for the Oldest Old Participants May have the Potential to Reduce Emergency Admission: Preliminary Evidence from a Pre-Post-Intervention Study.
Katipoglu B, Kocyigit SE, Ergun U, Kocak AO, et al · · 2025 · cited 2× · PMID 40316458 · DOI 10.1016/j.jemermed.2024.12.009
Impact of geriatric syndrome burden on healthcare services utilization and mortality among community-dwelling older adults: is it still too late to do something?
Katipoglu B, Kocyigit SE. · · 2025 · cited 2× · PMID 40120075 · DOI 10.1007/s41999-025-01189-w

Verify or expand the search:

Other trials of Comprehensive Geriatric Assessment

Trials testing the same drug.

NCT07487298 — G8 Screening Tool Validation in Older Adults With Cancer in Portugal · not yet recruiting
NCT07302737 — Delirium and Heart Failure · not yet recruiting
NCT06139627 — Evaluation of Geriatric Assessment and Management for Older Adults With Non-small Cell Lung Cancer Receiving Chemotherap · NA · recruiting
NCT06022965 — Telemedicine for Improvement of Care for Older Adults With Cancer in the Underserved Community, The GAIN-S Trial · NA · recruiting
NCT06052826 — Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years an · Phase 2 · recruiting

Other recruiting trials for Frailty

Currently open trials in the same condition.

NCT07481188 — Frailty and Nottingham Hip Fracture Score for Predicting 90-Day Mortality After Hip Fracture Surgery · recruiting
NCT07519603 — Frailty in Older Adults With Chronic Obstructive Pulmonary Disease (COPD) and Outcomes of the VIVIFRAIL Program · NA · recruiting
NCT07144527 — Nicotinamide Mononucleotide Supplementation for Exercise Tolerance Improvement in Healthy Older Adults · NA · recruiting
NCT07392944 — Multicomponent Exercise Program on Physical Function, Cognition and Falls Risk Among Older Adults Living in Nursing Home · NA · recruiting
NCT07475767 — Ultrasound Indicators of Nutritional Status and Treatment Outcomes in Surgical Patients in the Intensive Care Unit · recruiting

Other Gulhane Training and Research Hospital trials

Trials by the same sponsor.

NCT07283588 — İntensive Care Sepsis Prevelance in Turkey (INSEP-TURK) · active not recruiting
NCT07145554 — f-ESWT vs Steroid Injection for Piriformis Syndrome · NA · completed
NCT07039370 — Molecular Signatures of TMS Response in Treatment-Resistant Depression · NA · recruiting
NCT06995222 — The Role of Renal Resistive Index (RI) in Predicting Acute Kidney Injury Progression in Intensive Care Clinic · recruiting
NCT06765031 — The Role of Furosemide Stress Test in the Intensive Care Clinic · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05993572 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Gulhane Training and Research Hospital
Last refreshed: 6 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05993572.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing